Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,990.00    -10.00 (-0.20%)
Bid:
4,950.00
Ask:
5,030.00
Spread: 80.00 (1.616%)
Market Cap: £332.37m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Total Voting Rights

1 Dec 2023 11:20

RNS Number : 4179V
Judges Scientific PLC
01 December 2023

Press Release

Judges Scientific plc

("Judges Scientific")

Total Voting Rights

Judges Scientific confirms that, as at 1 December 2023, the total issued share capital has increased to 6,615,017 Ordinary shares of 5p each ("Ordinary Share").

There are no Ordinary Shares held in treasury. Each Ordinary Share carries voting rights on the basis of one vote per Ordinary Share. Therefore, the total number of voting rights in Judges Scientific is 6,615,017 Ordinary Shares.

The above figure may be used by shareholders as the denominator for calculations to determine if they have a notifiable interest in Judges Scientific under the Disclosure and Transparency Rules, or if such interest has changed.

- Ends -

- For further information please contact:

Judges Scientific plc

David Cicurel, CEO

Brad Ormsby, CFO

Tel: +44 (0) 20 3829 6970

Shore Capital (Nominated Adviser & Joint Broker)

Stephane Auton

Iain Sexton

Tel: +44 (0) 20 7408 4090

Liberum (Joint Broker)

Edward Mansfield

Nikhil Varghese

Tel : +44 (0) 20 3100 2222

Investec Bank plc (Joint Broker)

Virginia Bull

Carlton Nelson

Tel: +44 (0) 207 597 4000

Alma PR (Financial Public Relations)

Sam Modlin

Rebecca Sanders-Hewitt

Joe Pederzolli

Tel: +44 (0) 20 3405 0205

judges@almastrategic.co.uk

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 22 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.

For further information, please visit www.judges.uk.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TVREAFAFEFNDFFA
Date   Source Headline
30th Mar 20123:49 pmRNSDirector/PDMR Shareholding and Exercise of Options
29th Mar 20127:00 amRNSFinal Results
12th Mar 20126:17 pmRNSHolding(s) in Company
7th Mar 20127:00 amRNSACQUISITION OF GLOBAL DIGITAL SYSTEMS LIMITED
22nd Feb 201210:00 amRNSAcquisition of KE Developments Limited
19th Jan 20127:00 amRNSTrading Statement
16th Nov 20117:00 amRNSTrading Statement
6th Oct 201111:59 amRNSDirector/PDMR Shareholding and Exercise of Options
28th Sep 20117:00 amRNSHalf Yearly Report
14th Sep 20117:00 amRNSNotice of Results
22nd Jul 20115:04 pmRNSDirector/PDMR Shareholding
18th Jul 20117:00 amRNSTrading Statement
27th May 20117:00 amRNSIssue of Equity
26th May 20114:28 pmRNSDirector/PDMR Shareholding
10th May 20117:00 amRNSDirector/PDMR Shareholding
28th Apr 20119:25 amRNSHolding(s) in Company
15th Apr 20115:03 pmRNSDirector/PDMR Shareholding
7th Apr 20112:48 pmRNSHolding(s) in Company
5th Apr 20116:05 pmRNSDirector/PDMR Shareholding
5th Apr 20115:44 pmRNSDirector/PDMR Shareholding
4th Apr 20116:28 pmRNSDirector/PDMR Shareholding
1st Apr 201110:51 amRNSHolding(s) in Company
30th Mar 20117:00 amRNSFinal Results
21st Mar 20117:00 amRNSAcquisition
4th Mar 20117:00 amRNSNotice of Results
20th Jan 20117:00 amRNSTrading Statement
13th Jan 201111:10 amRNSDirector/PDMR Shareholding
22nd Nov 20105:20 pmRNSExercise of options
17th Nov 20107:00 amRNSTrading Statement
11th Oct 20106:17 pmRNSHolding(s) in Company
28th Sep 20107:00 amRNSExercise of Options
22nd Sep 20107:00 amRNSHalf Yearly Report
9th Sep 20102:00 pmRNSNotice of Results
21st Jul 201012:08 pmRNSHolding(s) in Company
20th Jul 201012:04 pmRNSHolding(s) in Company
20th Jul 20109:13 amRNSDirector/PDMR Shareholding
16th Jul 20107:00 amRNSTrading Statement
25th May 201012:17 pmRNSResult of AGM
21st May 20109:35 amRNSIssue of Equity
26th Mar 20107:00 amRNSFinal Results
19th Mar 20107:00 amRNSAcquisition
4th Mar 20105:25 pmRNSNotice of Results
22nd Jan 201011:15 amRNSShare buyback programme
22nd Jan 20107:00 amRNSTrading Statement
14th Jan 201010:20 amRNSHolding(s) in Company
11th Dec 20097:00 amRNSTrading Statement
20th Oct 200910:55 amRNSExercise of options
2nd Oct 20097:00 amRNSDirector/PDMR Shareholding
29th Sep 20097:00 amRNSHalf Yearly Report
22nd Sep 20097:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.